These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 29116467)
1. Vitamin D supplementation decreases serum 27-hydroxycholesterol in a pilot breast cancer trial. Going CC; Alexandrova L; Lau K; Yeh CY; Feldman D; Pitteri SJ Breast Cancer Res Treat; 2018 Feb; 167(3):797-802. PubMed ID: 29116467 [TBL] [Abstract][Full Text] [Related]
2. Impact of 27-hydroxylase (CYP27A1) and 27-hydroxycholesterol in breast cancer. Kimbung S; Chang CY; Bendahl PO; Dubois L; Thompson JW; McDonnell DP; Borgquist S Endocr Relat Cancer; 2017 Jul; 24(7):339-349. PubMed ID: 28442559 [TBL] [Abstract][Full Text] [Related]
3. Circulating 27-hydroxycholesterol and breast cancer tissue expression of CYP27A1, CYP7B1, LXR-β, and ERβ: results from the EPIC-Heidelberg cohort. Le Cornet C; Walter B; Sookthai D; Johnson TS; Kühn T; Herpel E; Kaaks R; Fortner RT Breast Cancer Res; 2020 Feb; 22(1):23. PubMed ID: 32075687 [TBL] [Abstract][Full Text] [Related]
4. 27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology. Nelson ER; Wardell SE; Jasper JS; Park S; Suchindran S; Howe MK; Carver NJ; Pillai RV; Sullivan PM; Sondhi V; Umetani M; Geradts J; McDonnell DP Science; 2013 Nov; 342(6162):1094-8. PubMed ID: 24288332 [TBL] [Abstract][Full Text] [Related]
5. Circulating 27-Hydroxycholesterol and Breast Cancer Risk: Results From the EPIC-Heidelberg Cohort. Lu DL; Le Cornet C; Sookthai D; Johnson TS; Kaaks R; Fortner RT J Natl Cancer Inst; 2019 Apr; 111(4):365-371. PubMed ID: 30016454 [TBL] [Abstract][Full Text] [Related]
6. Dietary vitamin D₃ and 1,25-dihydroxyvitamin D₃ (calcitriol) exhibit equivalent anticancer activity in mouse xenograft models of breast and prostate cancer. Swami S; Krishnan AV; Wang JY; Jensen K; Horst R; Albertelli MA; Feldman D Endocrinology; 2012 Jun; 153(6):2576-87. PubMed ID: 22454149 [TBL] [Abstract][Full Text] [Related]
7. A narrow-band ultraviolet B course improves vitamin D balance and alters cutaneous CYP27A1 and CYP27B1 mRNA expression levels in haemodialysis patients supplemented with oral vitamin D. Ala-Houhala MJ; Vähävihu K; Snellman E; Hasan T; Kautiainen H; Karisola P; Dombrowski Y; Schauber J; Saha H; Reunala T Nephron Clin Pract; 2013; 124(1-2):17-22. PubMed ID: 24029861 [TBL] [Abstract][Full Text] [Related]
8. 27-Hydroxycholesterol acts on myeloid immune cells to induce T cell dysfunction, promoting breast cancer progression. Ma L; Wang L; Nelson AT; Han C; He S; Henn MA; Menon K; Chen JJ; Baek AE; Vardanyan A; Shahoei SH; Park S; Shapiro DJ; Nanjappa SG; Nelson ER Cancer Lett; 2020 Nov; 493():266-283. PubMed ID: 32861706 [TBL] [Abstract][Full Text] [Related]
9. CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients. Kimbung S; Inasu M; Stålhammar T; Nodin B; Elebro K; Tryggvadottir H; Ygland Rödström M; Jirström K; Isaksson K; Jernström H; Borgquist S Breast Cancer Res; 2020 Nov; 22(1):123. PubMed ID: 33176848 [TBL] [Abstract][Full Text] [Related]
12. Host CYP27A1 expression is essential for ovarian cancer progression. He S; Ma L; Baek AE; Vardanyan A; Vembar V; Chen JJ; Nelson AT; Burdette JE; Nelson ER Endocr Relat Cancer; 2019 Jul; 26(7):659-675. PubMed ID: 31048561 [TBL] [Abstract][Full Text] [Related]
13. 27-Hydroxycholesterol, an endogenous selective estrogen receptor modulator. He S; Nelson ER Maturitas; 2017 Oct; 104():29-35. PubMed ID: 28923174 [TBL] [Abstract][Full Text] [Related]
14. 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen. Umetani M; Domoto H; Gormley AK; Yuhanna IS; Cummins CL; Javitt NB; Korach KS; Shaul PW; Mangelsdorf DJ Nat Med; 2007 Oct; 13(10):1185-92. PubMed ID: 17873880 [TBL] [Abstract][Full Text] [Related]
15. The endogenous selective estrogen receptor modulator 27-hydroxycholesterol is a negative regulator of bone homeostasis. DuSell CD; Nelson ER; Wang X; Abdo J; Mödder UI; Umetani M; Gesty-Palmer D; Javitt NB; Khosla S; McDonnell DP Endocrinology; 2010 Aug; 151(8):3675-85. PubMed ID: 20501668 [TBL] [Abstract][Full Text] [Related]
16. Main endocrine modulators of vitamin D hydroxylases in human pathophysiology. Caniggia A; Lorè F; di Cairano G; Nuti R J Steroid Biochem; 1987; 27(4-6):815-24. PubMed ID: 3320561 [TBL] [Abstract][Full Text] [Related]
17. The ROS-mediated activation of STAT-3/VEGF signaling is involved in the 27-hydroxycholesterol-induced angiogenesis in human breast cancer cells. Zhu D; Shen Z; Liu J; Chen J; Liu Y; Hu C; Li Z; Li Y Toxicol Lett; 2016 Dec; 264():79-86. PubMed ID: 27856279 [TBL] [Abstract][Full Text] [Related]
18. Vitamin D status and gene transcription in immune cells. Morán-Auth Y; Penna-Martinez M; Shoghi F; Ramos-Lopez E; Badenhoop K J Steroid Biochem Mol Biol; 2013 Jul; 136():83-5. PubMed ID: 23416105 [TBL] [Abstract][Full Text] [Related]
19. Association between lifestyle, dietary, reproductive, and anthropometric factors and circulating 27-hydroxycholesterol in EPIC-Heidelberg. Le Cornet C; Johnson TS; Lu DL; Kaaks R; Fortner RT Cancer Causes Control; 2020 Feb; 31(2):181-192. PubMed ID: 31938951 [TBL] [Abstract][Full Text] [Related]